Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Sentante is a robotics company founded 2017, based in LT, developing 1 robot primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
Sentante has raised US$6.6M across 1 confirmed round and has no deployment evidence on file.
Raised
US$6.6M
across 1 confirmed round · latest Dec 2023 · Seed
- Dec 2023· Seed· US$6.6M· led by Practica Capital· Tech.eu ↗· 3 outlets
Confirmed rounds recorded from January 2017. Every amount links to its source.
Correct this →Shipped
No deployment evidence on file
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Sentante.
In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.
Add a deployment →Teleoperated endovascular robotics
Sentante is a Vilnius, Lithuania medical-robotics company, founded in 2017, developing a haptic teleoperated endovascular robotic platform for remote vascular procedures. Its system received a CE mark in 2026.
Active products
1
RoboIndex
48.94
RoboScore 45.44 + Momentum 3.50
Company facts
- HQ
- Vilnius, LT
- Founded
- 2017 · 9 yrs
- Stage
- Seed · Dec 2023
- Website
- sentante.com
RoboScore
45.44 RoboScore + 3.50 Momentum· Adequate evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
In the news
4 events · last 90 days
+3.50momentumof 15 maxSentante’s Endovascular Robot Enters Commercial Use in Vascular Surgery
In the news
4 events · last 90 days
Why Sentante has been in the news, across 3 outlets — collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore — the evidence half of the RoboIndex — and it can move a robot up a board by at most 15 points.
Public loss record
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Active products by Sentante
1 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 | Sentante Endovascular Robotic System | Surgical / Medical | 2026 | 41.3 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…